People working at large pharmaceutical firms will stand out from their colleagues if they stay on top of who's doing what at smaller firms, so their company can strike up joint ventures that fatten their early pipeline, suggests Tamara Zemlo, director of scientific and medical communications at the Science Advisory Board (see "Picking Up the Slack," page 11). This may involve keeping in touch with former graduate students or advisors who are working in promising disease areas, she explains. "You need to bring more to the table," says Zemlo.
The best way for scientists to stay afloat if offshoring picks up is to keep abreast of cutting-edge technologies in their field, perhaps through continuing education courses, says Ames Gross, president of Pacific Bridge Medical. Scientists need to "stay on top of the industry, so they can add value over here," he says. Employers are also attracted to scientists who are ...
